{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:08:19Z","timestamp":1793178499981,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ajog.2004.12.067","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:21:11Z","timestamp":1113834071000},"page":"1316-1323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The effects of progestins on bone density and bone metabolism in postmenopausal women: A randomized controlled trial"],"prefix":"10.1016","volume":"192","author":[{"given":"James H.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken N.","family":"Muse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2004.12.067_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/oxfordjournals.epirev.a036281","article-title":"Epidemiology of osteoporosis and osteoporotic fractures","volume":"7","author":"Cummings","year":"1985","journal-title":"Epidemiology Rev"},{"key":"10.1016\/j.ajog.2004.12.067_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risk and benefits of estrogen plus progesterone in healthy postmenopausal women","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.12.067_bib3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.12.067_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/bmj.289.6444.517","article-title":"Impaired osteoblast function in osteoporosis: a comparison between calcium intake and dynamic histomorphometry","volume":"289","author":"Arlot","year":"1984","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2004.12.067_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jbmr.5650020605","article-title":"Total bone calcium in normal women: effect of age and menopause status","volume":"2","author":"Gallagher","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajog.2004.12.067_bib6","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1677\/joe.0.133R005","article-title":"Oestrogen and progestogen synergistically stimulate human and rat osteoblast proliferation","volume":"133","author":"Slotweg","year":"1992","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ajog.2004.12.067_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1097-4644(20001101)79:2<334::AID-JCB160>3.0.CO;2-M","article-title":"Membrane signaling and progesterone in female and male osteoblasts. I: involvement Ca2+, inositol triphosphate, and diacylglycerol, but not cAMP","volume":"79","author":"Grosse","year":"2000","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ajog.2004.12.067_bib8","first-page":"384","article-title":"Osteoporosis reversal: the role of progesterone","volume":"10","author":"Lee","year":"1990","journal-title":"Clin Nutr Rev"},{"key":"10.1016\/j.ajog.2004.12.067_bib9","first-page":"789","article-title":"Prevention of bone mineral loss in postmenopausal women by norethisterone","volume":"66","author":"Abdalla","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.12.067_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9343(91)90538-9","article-title":"Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen","volume":"90","author":"Gallagher","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2004.12.067_bib11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jama.1996.03540170041030","article-title":"The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial","volume":"276","author":"Speroff","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2004.12.067_bib12","first-page":"558","article-title":"Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial","volume":"75","author":"Surrey","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2004.12.067_bib13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jcem-70-4-920","article-title":"Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonst?","volume":"70","author":"Riis","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2004.12.067_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.GME.0000070524.74726.18","article-title":"Urinary \u03b2-FSH subunit concentrations in perimenopausal and postmenopausal women: a biomarker for ovarian reserve","volume":"10","author":"Liu","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2004.12.067_bib15","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","article-title":"Bone mineral density thresholds for pharmacological intervention to prevent fractures","volume":"164","author":"Siris","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajog.2004.12.067_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/edrv-11-2-386","article-title":"Progesterone as a bone trophic hormone","volume":"11","author":"Prior","year":"1990","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.ajog.2004.12.067_bib17","first-page":"225","article-title":"Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss","volume":"94","author":"Leonetti","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.12.067_bib18","first-page":"13","article-title":"Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women","volume":"10","author":"Wren","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2004.12.067_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0002-9343(94)90092-2","article-title":"Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances","volume":"96","author":"Prior","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2004.12.067_bib20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1359\/jbmr.1997.12.11.1851","article-title":"Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate","volume":"12","author":"Prior","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajog.2004.12.067_bib21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/humrep\/12.3.436","article-title":"Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability","volume":"12","author":"Caird","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.12.067_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0020-7292(91)90359-D","article-title":"Prevention of osteoporosis by medroxyprogesterone acetate in postmenopausal women","volume":"34","author":"McNeely","year":"1991","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2004.12.067_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1471-0528.1997.tb10651.x","article-title":"A double-blind randomized controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapy","volume":"104","author":"Adachi","year":"1997","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.12.067_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2265.1993.tb02422.x","article-title":"Effects of norethisterone on bone related biochemical variables and forearm bone loss in postmenopausal osteoporosis","volume":"39","author":"Horowitz","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ajog.2004.12.067_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.12.067_bib26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s001980050176","article-title":"The effects of low dose norethisterone on biochemical variables in postmenopausal women","volume":"9","author":"Scopacasa","year":"1999","journal-title":"Osteoporos Int"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937805000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937805000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:59:18Z","timestamp":1757584758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937805000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0002937805000438"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2004.12.067","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of progestins on bone density and bone metabolism in postmenopausal women: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2004.12.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}